Project Number 2021JS Agency/Funding Organization Cure Alzheimer's Fund Funding Year 2021 View Full Project Details for Interrogating levetiracetam’s impact on amyloid pathology and presynaptic proteostasis in knock-in mouse models with humanized Abeta Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) a. Amyloid beta Researcher and Organization Principal Investigator Savas, Jeffrey Principal Investigator Savas, Jeffrey Awardee Organization Northwestern Awardee State Illinois Contact PI Country United States Project Detail Funding Opportunity Announcement 2021 Research Grants FY Overall Cost $164,314 Funding Organization Agency/Funding Organization Cure Alzheimer's Fund Funding Organization Country United States Program Official CureAlzFund
